Stock Trading CanaryHONG KONG · DIRECTORS' NOTICES
Tianda Pharmaceuticals Ltd.
00455 · Healthcare · Drug Manufacturers—Specialty & Generic
Score
Not ranked: no net buying on the exchange by a director in the last 180 days.
Director trades on the exchange
Purchases and sales on the exchange in the last 12 months, as counted in the score.
No purchase on the exchange by a director is on record yet.
Purchases not counted · 10
Director notices of a purchase that the score leaves out, and why.
| Trade date | Director | Why not counted | Shares |
|---|---|---|---|
| 2023-01-20 | Fang Wen Quan | Replaced by an amendment | 288,000 |
| 2023-01-06 | Fang Wen Quan | Replaced by an amendment | 42,000 |
| 2023-01-05 | Fang Wen Quan | Replaced by an amendment | 110,000 |
| 2023-01-04 | Fang Wen Quan | Replaced by an amendment | 568,000 |
| 2023-01-03 | Fang Wen Quan | Replaced by an amendment | 390,000 |
| 2022-01-20 | Fang Wen Quan | Replaced by an amendment | 288,000 |
| 2022-01-06 | Fang Wen Quan | Replaced by an amendment | 42,000 |
| 2022-01-05 | Fang Wen Quan | Replaced by an amendment | 110,000 |
| 2022-01-04 | Fang Wen Quan | Replaced by an amendment | 568,000 |
| 2022-01-03 | Fang Wen Quan | Replaced by an amendment | 390,000 |